Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers

scientific article published on 01 September 2006

Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/01.MJT.0000182358.63457.48
P698PubMed publication ID16988537

P50authorPaul GlueQ30668714
P2093author name stringAnnie Fang
Kuan Gandelman
Brian Klee
P433issue5
P921main subjectpharmacokineticsQ323936
P304page(s)418-422
P577publication date2006-09-01
P1433published inAmerican Journal of TherapeuticsQ15754773
P1476titlePharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers
P478volume13

Reverse relations

cites work (P2860)
Q48312001Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.
Q85051105Effect of an oral anxiolytic medication and heart rate variability on image quality of 64-slice MDCT coronary angiography
Q36813937Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
Q47642128The Black Book of Psychotropic Dosing and Monitoring

Search more.